Overall, although a number of studies have analyzed the co-carriage of KIR genes and their ligands, general conclusions regarding the role of aKIR in cancer and cancer therapy cannot be drawn, as it is likely that the role of aKIRs will vary depending on the type of cancer and treatment. This evidence concerns the gene KIR3DL1 and cancer.